Cite
HARVARD Citation
Vitek, G. et al. (2023). Lecanemab (BAN2401): an anti–beta-amyloid monoclonal antibody for the treatment of Alzheimer disease. Expert opinion on investigational drugs. pp. 89-94. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vitek, G. et al. (2023). Lecanemab (BAN2401): an anti–beta-amyloid monoclonal antibody for the treatment of Alzheimer disease. Expert opinion on investigational drugs. pp. 89-94. [Online].